Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.00001
-
Shares outstanding
-
62,162,717
-
Total 13F shares
-
17,192,544
-
Share change
-
+2,205,464
-
Total reported value
-
$208,120,560
-
Price per share
-
$12.11
-
Number of holders
-
62
-
Value change
-
+$26,366,903
-
Number of buys
-
43
-
Number of sells
-
27
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX) as of Q2 2019
As of 30 Jun 2019 Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX) had 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,192,544 shares of stock of the company.
Largest 10 holders included FMR LLC, FARALLON CAPITAL MANAGEMENT LLC, VHCP Management III, LLC, BVF INC/IL, BlackRock Inc., BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, and ACUTA CAPITAL PARTNERS, LLC.
This table shows 62 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.